Ahmad FB, Anderson RN. The leading causes of death in the US for 2020. JAMA 2021; 325:1829–1830. doi: 10.1001/jama.2021.5469

• PubMed
Ahmad FB, Anderson RN. The leading causes of death in the US for 2020. JAMA 2021; 325:1829–1830. doi: 10.1001/jama.2021.5469)| false
• Search Google Scholar
• Export Citation

Rahimi K, et al. Cardiovascular disease and multimorbidity: A call for interdisciplinary research and personalized cardiovascular care. PLoS Med 2018; 15:e1002545. doi: 10.1371/journal.pmed.1002545

• PubMed
Rahimi K, Cardiovascular disease and multimorbidity: A call for interdisciplinary research and personalized cardiovascular care. PLoS Med 2018; 15:e1002545. doi: 10.1371/journal.pmed.1002545)| false
• Search Google Scholar
• Export Citation

Sarafidis P, et al. SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA. Nephrol Dial Transplant 2019; 34:208–230. doi: 10.1093/ndt/gfy407

• PubMed
Sarafidis P, SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA. Nephrol Dial Transplant 2019; 34:208–230. doi: 10.1093/ndt/gfy407)| false
• Search Google Scholar
• Export Citation

Diabetes mellitus: A major risk factor for cardiovascular disease. A joint editorial statement by the American Diabetes Association; The National Heart, Lung, and Blood Institute; The Juvenile Diabetes Foundation International; The National Institute of Diabetes and Digestive and Kidney Diseases; and The American Heart Association. Circulation 1999; 100:1132–1133. doi: 10.1161/01.cir.100.10.1132

• PubMed
Diabetes mellitus: A major risk factor for cardiovascular disease. A joint editorial statement by the American Diabetes Association; The National Heart, Lung, and Blood Institute; The Juvenile Diabetes Foundation International; The National Institute of Diabetes and Digestive and Kidney Diseases; and The American Heart Association. Circulation 1999; 100:1132–1133. doi: 10.1161/01.cir.100.10.1132)| false
• Search Google Scholar
• Export Citation

Hebert SA, Ibrahim HN. Hypertension management in patients with chronic kidney disease. Methodist Debakey Cardiovasc J 2022; 18:41–49. doi: 10.14797/mdcvj.1119

• PubMed
Hebert SA, Ibrahim HN. Hypertension management in patients with chronic kidney disease. Methodist Debakey Cardiovasc J 2022; 18:41–49. doi: 10.14797/mdcvj.1119)| false
• Search Google Scholar
• Export Citation

Ostrominski JW, et al. Prevalence and overlap of cardiac, renal, and metabolic conditions in US adults, 1999-2020. JAMA Cardiol 2023; 8:1050–1060. doi: 10.1001/jamacardio.2023.3241

• PubMed
Ostrominski JW, Prevalence and overlap of cardiac, renal, and metabolic conditions in US adults, 1999-2020. JAMA Cardiol 2023; 8:1050–1060. doi: 10.1001/jamacardio.2023.3241)| false
• Search Google Scholar
• Export Citation

Eberly LA, et al. Racial, ethnic, and socioeconomic inequities in glucagon-like peptide-1 receptor agonist use among patients with diabetes in the US. JAMA Health Forum 2021; 2:e214182. doi: 10.1001/jamahealthforum.2021.4182

• PubMed
Eberly LA, Racial, ethnic, and socioeconomic inequities in glucagon-like peptide-1 receptor agonist use among patients with diabetes in the US. JAMA Health Forum 2021; 2:e214182. doi: 10.1001/jamahealthforum.2021.4182)| false
• Search Google Scholar
• Export Citation

Das SR, et al. 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol 2020; 76:1117–1145. doi: 10.1016/j.jacc.2020.05.037

• PubMed
Das SR, 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol 2020; 76:1117–1145. doi: 10.1016/j.jacc.2020.05.037)| false
• Search Google Scholar
• Export Citation

Cusick MM, et al. Population-wide screening for chronic kidney disease: A cost-effectiveness analysis. Ann Intern Med 2023; 176:788–797. doi: 10.7326/M22-3228

• PubMed
Cusick MM, Population-wide screening for chronic kidney disease: A cost-effectiveness analysis. Ann Intern Med 2023; 176:788–797. doi: 10.7326/M22-3228)| false
• Search Google Scholar
• Export Citation